世界のがん支持療法薬剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cancer Supportive Care Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5643
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、がん支持療法薬剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（G-CSF（顆粒球コロニー刺激因子）、ESA（赤血球生成刺激剤）、制吐剤、ビスフォスフォネート、オピオイド、NSAID）、用途別市場規模（化学療法、放射線療法）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・がん支持療法薬剤の市場動向
・企業の競争状況、市場シェア
・がん支持療法薬剤の種類別市場規模と予測2016-2027（G-CSF（顆粒球コロニー刺激因子）、ESA（赤血球生成刺激剤）、制吐剤、ビスフォスフォネート、オピオイド、NSAID）
・がん支持療法薬剤の用途別市場規模と予測2016-2027（化学療法、放射線療法）
・がん支持療法薬剤の北米市場規模2016-2027（アメリカ、カナダ）
・がん支持療法薬剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・がん支持療法薬剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・がん支持療法薬剤の中南米市場規模2016-2027（メキシコ、ブラジル）
・がん支持療法薬剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Amgen、Johnson & Johnson、Merck、Roche、Helsinn Healthcare、Heron Pharma、Tesaro）
・結論

Supportive drugs are not anticancer drugs. They protect certain cells or organs from the side effects of chemotherapy drugs or radiation therapy.
Increasing uptake of biosimilars, rising expenditure on healthcare, and availability of effective treatment methods, including target specific and tailored treatments are anticipated to drive the growth.

Market Analysis and Insights: Global Cancer Supportive Care Drugs Market
The global Cancer Supportive Care Drugs market size is projected to reach US$ 19170 million by 2027, from US$ 17400 million in 2020, at a CAGR of 3.3% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Supportive Care Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Supportive Care Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Supportive Care Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Supportive Care Drugs market.

Global Cancer Supportive Care Drugs Scope and Market Size
Cancer Supportive Care Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Supportive Care Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
G-CSFs (Granulocyte-colony Stimulating Factors)
ESAs (Erythropoiesis Stimulating Agents)
Anti-emetics
Bisphosphonates
Opioids
NSAIDs

Segment by Application
Chemotherapy Therapy
Radiation Therapy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen
Johnson & Johnson
Merck
Roche
Helsinn Healthcare
Heron Pharma
Tesaro

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Supportive Care Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 G-CSFs (Granulocyte-colony Stimulating Factors)
1.2.3 ESAs (Erythropoiesis Stimulating Agents)
1.2.4 Anti-emetics
1.2.5 Bisphosphonates
1.2.6 Opioids
1.2.7 NSAIDs
1.3 Market by Application
1.3.1 Global Cancer Supportive Care Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Chemotherapy Therapy
1.3.3 Radiation Therapy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cancer Supportive Care Drugs Market Perspective (2016-2027)
2.2 Cancer Supportive Care Drugs Growth Trends by Regions
2.2.1 Cancer Supportive Care Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Supportive Care Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Supportive Care Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Supportive Care Drugs Industry Dynamic
2.3.1 Cancer Supportive Care Drugs Market Trends
2.3.2 Cancer Supportive Care Drugs Market Drivers
2.3.3 Cancer Supportive Care Drugs Market Challenges
2.3.4 Cancer Supportive Care Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cancer Supportive Care Drugs Players by Revenue
3.1.1 Global Top Cancer Supportive Care Drugs Players by Revenue (2016-2021)
3.1.2 Global Cancer Supportive Care Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Supportive Care Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Supportive Care Drugs Revenue
3.4 Global Cancer Supportive Care Drugs Market Concentration Ratio
3.4.1 Global Cancer Supportive Care Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Supportive Care Drugs Revenue in 2020
3.5 Cancer Supportive Care Drugs Key Players Head office and Area Served
3.6 Key Players Cancer Supportive Care Drugs Product Solution and Service
3.7 Date of Enter into Cancer Supportive Care Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Supportive Care Drugs Breakdown Data by Type
4.1 Global Cancer Supportive Care Drugs Historic Market Size by Type (2016-2021)
4.2 Global Cancer Supportive Care Drugs Forecasted Market Size by Type (2022-2027)

5 Cancer Supportive Care Drugs Breakdown Data by Application
5.1 Global Cancer Supportive Care Drugs Historic Market Size by Application (2016-2021)
5.2 Global Cancer Supportive Care Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cancer Supportive Care Drugs Market Size (2016-2027)
6.2 North America Cancer Supportive Care Drugs Market Size by Type
6.2.1 North America Cancer Supportive Care Drugs Market Size by Type (2016-2021)
6.2.2 North America Cancer Supportive Care Drugs Market Size by Type (2022-2027)
6.2.3 North America Cancer Supportive Care Drugs Market Size by Type (2016-2027)
6.3 North America Cancer Supportive Care Drugs Market Size by Application
6.3.1 North America Cancer Supportive Care Drugs Market Size by Application (2016-2021)
6.3.2 North America Cancer Supportive Care Drugs Market Size by Application (2022-2027)
6.3.3 North America Cancer Supportive Care Drugs Market Size by Application (2016-2027)
6.4 North America Cancer Supportive Care Drugs Market Size by Country
6.4.1 North America Cancer Supportive Care Drugs Market Size by Country (2016-2021)
6.4.2 North America Cancer Supportive Care Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cancer Supportive Care Drugs Market Size (2016-2027)
7.2 Europe Cancer Supportive Care Drugs Market Size by Type
7.2.1 Europe Cancer Supportive Care Drugs Market Size by Type (2016-2021)
7.2.2 Europe Cancer Supportive Care Drugs Market Size by Type (2022-2027)
7.2.3 Europe Cancer Supportive Care Drugs Market Size by Type (2016-2027)
7.3 Europe Cancer Supportive Care Drugs Market Size by Application
7.3.1 Europe Cancer Supportive Care Drugs Market Size by Application (2016-2021)
7.3.2 Europe Cancer Supportive Care Drugs Market Size by Application (2022-2027)
7.3.3 Europe Cancer Supportive Care Drugs Market Size by Application (2016-2027)
7.4 Europe Cancer Supportive Care Drugs Market Size by Country
7.4.1 Europe Cancer Supportive Care Drugs Market Size by Country (2016-2021)
7.4.2 Europe Cancer Supportive Care Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cancer Supportive Care Drugs Market Size (2016-2027)
8.2 Asia-Pacific Cancer Supportive Care Drugs Market Size by Type
8.2.1 Asia-Pacific Cancer Supportive Care Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Supportive Care Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Supportive Care Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Supportive Care Drugs Market Size by Application
8.3.1 Asia-Pacific Cancer Supportive Care Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Supportive Care Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Supportive Care Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Supportive Care Drugs Market Size by Region
8.4.1 Asia-Pacific Cancer Supportive Care Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Supportive Care Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cancer Supportive Care Drugs Market Size (2016-2027)
9.2 Latin America Cancer Supportive Care Drugs Market Size by Type
9.2.1 Latin America Cancer Supportive Care Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Supportive Care Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Supportive Care Drugs Market Size by Type (2016-2027)
9.3 Latin America Cancer Supportive Care Drugs Market Size by Application
9.3.1 Latin America Cancer Supportive Care Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Supportive Care Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Supportive Care Drugs Market Size by Application (2016-2027)
9.4 Latin America Cancer Supportive Care Drugs Market Size by Country
9.4.1 Latin America Cancer Supportive Care Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Supportive Care Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cancer Supportive Care Drugs Market Size (2016-2027)
10.2 Middle East & Africa Cancer Supportive Care Drugs Market Size by Type
10.2.1 Middle East & Africa Cancer Supportive Care Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Supportive Care Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Supportive Care Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Supportive Care Drugs Market Size by Application
10.3.1 Middle East & Africa Cancer Supportive Care Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Supportive Care Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Supportive Care Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Supportive Care Drugs Market Size by Country
10.4.1 Middle East & Africa Cancer Supportive Care Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Supportive Care Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Cancer Supportive Care Drugs Introduction
11.1.4 Amgen Revenue in Cancer Supportive Care Drugs Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Cancer Supportive Care Drugs Introduction
11.2.4 Johnson & Johnson Revenue in Cancer Supportive Care Drugs Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Cancer Supportive Care Drugs Introduction
11.3.4 Merck Revenue in Cancer Supportive Care Drugs Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Cancer Supportive Care Drugs Introduction
11.4.4 Roche Revenue in Cancer Supportive Care Drugs Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Helsinn Healthcare
11.5.1 Helsinn Healthcare Company Details
11.5.2 Helsinn Healthcare Business Overview
11.5.3 Helsinn Healthcare Cancer Supportive Care Drugs Introduction
11.5.4 Helsinn Healthcare Revenue in Cancer Supportive Care Drugs Business (2016-2021)
11.5.5 Helsinn Healthcare Recent Development
11.6 Heron Pharma
11.6.1 Heron Pharma Company Details
11.6.2 Heron Pharma Business Overview
11.6.3 Heron Pharma Cancer Supportive Care Drugs Introduction
11.6.4 Heron Pharma Revenue in Cancer Supportive Care Drugs Business (2016-2021)
11.6.5 Heron Pharma Recent Development
11.7 Tesaro
11.7.1 Tesaro Company Details
11.7.2 Tesaro Business Overview
11.7.3 Tesaro Cancer Supportive Care Drugs Introduction
11.7.4 Tesaro Revenue in Cancer Supportive Care Drugs Business (2016-2021)
11.7.5 Tesaro Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cancer Supportive Care Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of G-CSFs (Granulocyte-colony Stimulating Factors)
Table 3. Key Players of ESAs (Erythropoiesis Stimulating Agents)
Table 4. Key Players of Anti-emetics
Table 5. Key Players of Bisphosphonates
Table 6. Key Players of Opioids
Table 7. Key Players of NSAIDs
Table 8. Global Cancer Supportive Care Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Cancer Supportive Care Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Cancer Supportive Care Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Cancer Supportive Care Drugs Market Share by Regions (2016-2021)
Table 12. Global Cancer Supportive Care Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Cancer Supportive Care Drugs Market Share by Regions (2022-2027)
Table 14. Cancer Supportive Care Drugs Market Trends
Table 15. Cancer Supportive Care Drugs Market Drivers
Table 16. Cancer Supportive Care Drugs Market Challenges
Table 17. Cancer Supportive Care Drugs Market Restraints
Table 18. Global Cancer Supportive Care Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Cancer Supportive Care Drugs Market Share by Players (2016-2021)
Table 20. Global Top Cancer Supportive Care Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Supportive Care Drugs as of 2020)
Table 21. Ranking of Global Top Cancer Supportive Care Drugs Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Cancer Supportive Care Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cancer Supportive Care Drugs Product Solution and Service
Table 25. Date of Enter into Cancer Supportive Care Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cancer Supportive Care Drugs Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Cancer Supportive Care Drugs Revenue Market Share by Type (2016-2021)
Table 29. Global Cancer Supportive Care Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Cancer Supportive Care Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Cancer Supportive Care Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Cancer Supportive Care Drugs Revenue Market Share by Application (2016-2021)
Table 33. Global Cancer Supportive Care Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Cancer Supportive Care Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Cancer Supportive Care Drugs Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Cancer Supportive Care Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Cancer Supportive Care Drugs Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Cancer Supportive Care Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Cancer Supportive Care Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Cancer Supportive Care Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Cancer Supportive Care Drugs Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Cancer Supportive Care Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Cancer Supportive Care Drugs Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Cancer Supportive Care Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Cancer Supportive Care Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Cancer Supportive Care Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cancer Supportive Care Drugs Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cancer Supportive Care Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cancer Supportive Care Drugs Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Cancer Supportive Care Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Cancer Supportive Care Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Cancer Supportive Care Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Cancer Supportive Care Drugs Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Cancer Supportive Care Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Cancer Supportive Care Drugs Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Cancer Supportive Care Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Cancer Supportive Care Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Cancer Supportive Care Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cancer Supportive Care Drugs Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cancer Supportive Care Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cancer Supportive Care Drugs Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Cancer Supportive Care Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Cancer Supportive Care Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Cancer Supportive Care Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 65. Amgen Company Details
Table 66. Amgen Business Overview
Table 67. Amgen Cancer Supportive Care Drugs Product
Table 68. Amgen Revenue in Cancer Supportive Care Drugs Business (2016-2021) & (US$ Million)
Table 69. Amgen Recent Development
Table 70. Johnson & Johnson Company Details
Table 71. Johnson & Johnson Business Overview
Table 72. Johnson & Johnson Cancer Supportive Care Drugs Product
Table 73. Johnson & Johnson Revenue in Cancer Supportive Care Drugs Business (2016-2021) & (US$ Million)
Table 74. Johnson & Johnson Recent Development
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Cancer Supportive Care Drugs Product
Table 78. Merck Revenue in Cancer Supportive Care Drugs Business (2016-2021) & (US$ Million)
Table 79. Merck Recent Development
Table 80. Roche Company Details
Table 81. Roche Business Overview
Table 82. Roche Cancer Supportive Care Drugs Product
Table 83. Roche Revenue in Cancer Supportive Care Drugs Business (2016-2021) & (US$ Million)
Table 84. Roche Recent Development
Table 85. Helsinn Healthcare Company Details
Table 86. Helsinn Healthcare Business Overview
Table 87. Helsinn Healthcare Cancer Supportive Care Drugs Product
Table 88. Helsinn Healthcare Revenue in Cancer Supportive Care Drugs Business (2016-2021) & (US$ Million)
Table 89. Helsinn Healthcare Recent Development
Table 90. Heron Pharma Company Details
Table 91. Heron Pharma Business Overview
Table 92. Heron Pharma Cancer Supportive Care Drugs Product
Table 93. Heron Pharma Revenue in Cancer Supportive Care Drugs Business (2016-2021) & (US$ Million)
Table 94. Heron Pharma Recent Development
Table 95. Tesaro Company Details
Table 96. Tesaro Business Overview
Table 97. Tesaro Cancer Supportive Care Drugs Product
Table 98. Tesaro Revenue in Cancer Supportive Care Drugs Business (2016-2021) & (US$ Million)
Table 99. Tesaro Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Supportive Care Drugs Market Share by Type: 2020 VS 2027
Figure 2. G-CSFs (Granulocyte-colony Stimulating Factors) Features
Figure 3. ESAs (Erythropoiesis Stimulating Agents) Features
Figure 4. Anti-emetics Features
Figure 5. Bisphosphonates Features
Figure 6. Opioids Features
Figure 7. NSAIDs Features
Figure 8. Global Cancer Supportive Care Drugs Market Share by Application: 2020 VS 2027
Figure 9. Chemotherapy Therapy Case Studies
Figure 10. Radiation Therapy Case Studies
Figure 11. Cancer Supportive Care Drugs Report Years Considered
Figure 12. Global Cancer Supportive Care Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Cancer Supportive Care Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Cancer Supportive Care Drugs Market Share by Regions: 2020 VS 2027
Figure 15. Global Cancer Supportive Care Drugs Market Share by Regions (2022-2027)
Figure 16. Global Cancer Supportive Care Drugs Market Share by Players in 2020
Figure 17. Global Top Cancer Supportive Care Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Supportive Care Drugs as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Cancer Supportive Care Drugs Revenue in 2020
Figure 19. Global Cancer Supportive Care Drugs Revenue Market Share by Type (2016-2021)
Figure 20. Global Cancer Supportive Care Drugs Revenue Market Share by Type (2022-2027)
Figure 21. North America Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Cancer Supportive Care Drugs Market Share by Type (2016-2027)
Figure 23. North America Cancer Supportive Care Drugs Market Share by Application (2016-2027)
Figure 24. North America Cancer Supportive Care Drugs Market Share by Country (2016-2027)
Figure 25. United States Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Cancer Supportive Care Drugs Market Share by Type (2016-2027)
Figure 29. Europe Cancer Supportive Care Drugs Market Share by Application (2016-2027)
Figure 30. Europe Cancer Supportive Care Drugs Market Share by Country (2016-2027)
Figure 31. Germany Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Cancer Supportive Care Drugs Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Cancer Supportive Care Drugs Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Cancer Supportive Care Drugs Market Share by Region (2016-2027)
Figure 41. China Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Cancer Supportive Care Drugs Market Share by Type (2016-2027)
Figure 49. Latin America Cancer Supportive Care Drugs Market Share by Application (2016-2027)
Figure 50. Latin America Cancer Supportive Care Drugs Market Share by Country (2016-2027)
Figure 51. Mexico Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Cancer Supportive Care Drugs Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Cancer Supportive Care Drugs Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Cancer Supportive Care Drugs Market Share by Country (2016-2027)
Figure 57. Turkey Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Cancer Supportive Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Amgen Revenue Growth Rate in Cancer Supportive Care Drugs Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Cancer Supportive Care Drugs Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Cancer Supportive Care Drugs Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Cancer Supportive Care Drugs Business (2016-2021)
Figure 64. Helsinn Healthcare Revenue Growth Rate in Cancer Supportive Care Drugs Business (2016-2021)
Figure 65. Heron Pharma Revenue Growth Rate in Cancer Supportive Care Drugs Business (2016-2021)
Figure 66. Tesaro Revenue Growth Rate in Cancer Supportive Care Drugs Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年）

Global Non-small Cell Lung Cancer Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5895 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、非小細胞肺がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、小分子標的療法、化学療法、その他）、用途別市場規模（肺腺癌、肺扁平上皮癌、大細胞肺癌）、主要地域別市場規模（北米、アメリカ...

世界の胃がん治療薬市場規模・現状・予測（2021年-2027年）

Global Stomach Cancer Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4908 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、胃がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法薬、標的療法薬、生物学的療法、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧...

世界の腎臓癌＆腎細胞癌（RCC）治療薬市場規模・現状・予測（2021年-2027年）

Global Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5819 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、腎臓癌＆腎細胞癌（RCC）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アフィニトール（エベロリムス）、アバスチン（ベバシズマブ）、カボメティ（カボザンチニブ）、インリタ（アキシチニブ）、ネク...

世界の未分化甲状腺がん市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Market Size, Status and Forecast 2021-2027
QFJ1-3801 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がんの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジ...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年）

Global Oral Cancer Molecular Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4622 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、口腔がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の掻痒治療薬市場規模・現状・予測（2021年-2027年）

Global Pruritus Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5973 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、掻痒治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（局所、経口、非経口）、用途別市場規模（血液性そう痒症、腫瘍性そう痒症、腎性そう痒症、内分泌性そう痒症、胆汁うっ滞性そう痒症）、主要地域別市場規...

世界の喉頭がん分子診断市場規模・現状・予測（2021年-2027年）

Global Laryngeal Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4412 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、喉頭がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の前立腺がん市場規模・現状・予測（2021年-2027年）

Global Prostate Cancer Market Size, Status and Forecast 2021-2027
QFJ1-4769 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、前立腺がんの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン感受性前立腺がん、ホルモン不応性前立腺がん）、用途別市場規模（化学療法、ホルモン療法、標的療法、免疫療法）、主要地域別市場規模（北米、...

世界のβ-ラクタム系薬剤市場規模・現状・予測（2021年-2027年）

Global Beta-Lactam Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5615 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、β-ラクタム系薬剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ペニシリン、セファロスポリン、カルバペネム、モノバクテリア）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模...

世界の顆粒球コロニー刺激因子（G-CSF）薬剤市場規模・現状・予測（2021年-2027年） Granulocyte colony-stimulating factor (G-CSF or GCSF), also known as colony-stimulating factor 3 (CSF 3), is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream. Market Analysis and Insights: Global Granulocyte-Colony Stimulatin…
がん支持療法のグローバル市場調査 2019年 The global Cancer Supportive Care Medicine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cancer Supportive Care Medicine volume and value at global level, regional level and company level. From a …
世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers. The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drug…
世界の胃がん治療薬市場規模・現状・予測（2021年-2027年） Stomach Cancer Drugs are used to treat stomach malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Market Analysis and Insights: Global Stomach Cancer Drugs Market T…
世界の遺伝子検出用個別化癌治療市場規模・現状・予測（2021年-2027年） A method to provide patients with individualized treatment of cancer tumors Market Analysis and Insights: Global Gene Detection for Individualized Cancer Therapy Market The global Gene Detection for Individualized Cancer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX m…